G1 Therapeutics Inc (GTHX) stock is lower by -78.70% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GTHX stock a score of 34 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 3. GTHX's rank also includes a long-term technical score of 10. The fundamental score for GTHX is 90. In addition to the average rating from Wall Street analysts, GTHX stock has a mean target price of $32.20. This means analysts expect the stock to gain 604.60% over the next 12 months. GTHX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on GTHX!